Business Description
Jiangsu Cowin Biotech Co Ltd
ISIN : CNE100005NM2
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 27.56 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 10.75 | |||||
Beneish M-Score | -1.35 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23 | |||||
3-Year Book Growth Rate | 44.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.8 | |||||
9-Day RSI | 45.73 | |||||
14-Day RSI | 45.93 | |||||
6-1 Month Momentum % | -37.01 | |||||
12-1 Month Momentum % | -37.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.87 | |||||
Quick Ratio | 14.37 | |||||
Cash Ratio | 12.07 | |||||
Days Inventory | 283.06 | |||||
Days Sales Outstanding | 280.02 | |||||
Days Payable | 336.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.68 | |||||
Forward Dividend Yield % | 2.68 | |||||
5-Year Yield-on-Cost % | 2.67 | |||||
3-Year Average Share Buyback Ratio | -10.2 | |||||
Shareholder Yield % | 3.01 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.47 | |||||
Operating Margin % | -120.79 | |||||
Net Margin % | -95.26 | |||||
FCF Margin % | -110.12 | |||||
ROE % | -6.89 | |||||
ROA % | -6.29 | |||||
ROIC % | -19.32 | |||||
ROC (Joel Greenblatt) % | -27.58 | |||||
ROCE % | -7.57 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 16.12 | |||||
PB Ratio | 1.31 | |||||
Price-to-Tangible-Book | 1.34 | |||||
EV-to-EBIT | -9.9 | |||||
EV-to-EBITDA | -9.9 | |||||
EV-to-Revenue | 10.83 | |||||
EV-to-FCF | -10.09 | |||||
Price-to-Net-Current-Asset-Value | 2.36 | |||||
Price-to-Net-Cash | 3.02 | |||||
Earnings Yield (Greenblatt) % | -10.1 | |||||
FCF Yield % | -6.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Jiangsu Cowin Biotech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 123.201 | ||
EPS (TTM) (Â¥) | -1.052 | ||
Beta | 0 | ||
Volatility % | 48.27 | ||
14-Day RSI | 45.93 | ||
14-Day ATR (Â¥) | 1.071877 | ||
20-Day SMA (Â¥) | 18.7895 | ||
12-1 Month Momentum % | -37.67 | ||
52-Week Range (Â¥) | 14.02 - 38.16 | ||
Shares Outstanding (Mil) | 112.49 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jiangsu Cowin Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jiangsu Cowin Biotech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Jiangsu Cowin Biotech Co Ltd Frequently Asked Questions
What is Jiangsu Cowin Biotech Co Ltd(SHSE:688426)'s stock price today?
When is next earnings date of Jiangsu Cowin Biotech Co Ltd(SHSE:688426)?
Does Jiangsu Cowin Biotech Co Ltd(SHSE:688426) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |